Coronavirus Update: Gilead Ready To Unveil Remdesivir Price
Plus Developments From Vir and Eli Lilly
• By Scrip Team
Gilead's remdesivir has gained emergency use approval in the US and similar status in Japan, with the EU expected to issue a conditional marketing approval shortly
Keep up with the top pharma business news of the week. On the go.
